Malathi Anantha
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Drug Discovery top 10%
Papers in
- Biomaterials 27
- Nanoparticle-Based Drug Delivery 27
- Oncology 6
- Metal complexes synthesis and properties 3
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- Marcel B. Bally (34 shared papers)Murray S. Webb (6 shared papers)Mohamed Wehbe (11 shared papers)Katarina Edwards (5 shared papers)Nancy Dos Santos (5 shared papers)Ada W.Y. Leung (9 shared papers)Dawn Waterhouse (11 shared papers)Göran Karlsson (2 shared papers)
- Journals
- Journal of Controlled Release (8 papers)Drug Delivery and Translational Research (4 papers)Pharmaceutical Research (2 papers)Investigational New Drugs (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- CanadaSwedenNetherlands
In The Last Decade
Malathi Anantha
34 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 67
- Biomaterials 698
- Drug Discovery 8
- Pharmaceutical Science 47
- Genetics 51
- Oncology 120
Countries citing papers authored by Malathi Anantha
This map shows the geographic impact of Malathi Anantha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malathi Anantha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malathi Anantha more than expected).
Fields of papers citing papers by Malathi Anantha
This network shows the impact of papers produced by Malathi Anantha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malathi Anantha. The network helps show where Malathi Anantha may publish in the future.
Co-authors
The 25 scholars most cited alongside Malathi Anantha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 305 | |
| 2 | 2006 | 61 | |
| 3 | 2017 | 61 | |
| 4 | 2018 | 49 | |
| 5 | 2011 | 48 | |
| 6 | 2016 | 48 | |
| 7 | 2006 | 45 | |
| 8 | 2008 | 44 | |
| 9 | 2017 | 41 | |
| 10 | 2017 | 38 | |
| 11 | 2008 | 36 | |
| 12 | 2010 | 35 | |
| 13 | 2019 | 33 | |
| 14 | 2020 | 30 | |
| 15 | 2011 | 28 | |
| 16 | 2013 | 28 | |
| 17 | 2012 | 27 | |
| 18 | 2021 | 24 | |
| 19 | 2014 | 22 | |
| 20 | 2015 | 21 |
About Malathi Anantha
Malathi Anantha is a scholar working on Biomaterials, Oncology, Genetics, Molecular Biology and Toxicology, having authored 34 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (27 papers), Cancer therapeutics and mechanisms (5 papers), Glioma Diagnosis and Treatment (3 papers), Metal complexes synthesis and properties (3 papers), RNA Interference and Gene Delivery (2 papers), Bioactive Compounds and Antitumor Agents (1 paper), Drug Solubulity and Delivery Systems (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Biomaterials (698 citations), Drug Discovery (8 citations), Pharmaceutical Science (47 citations), Genetics (51 citations) and Oncology (120 citations). Malathi Anantha has collaborated with scholars based in Canada, Sweden and Netherlands. Frequent co-authors include Marcel B. Bally, Murray S. Webb, Mohamed Wehbe, Katarina Edwards, Nancy Dos Santos, Ada W.Y. Leung, Dawn Waterhouse, Göran Karlsson, Christine J. Allen and Lacey Samuels. Their work appears in journals such as Journal of Controlled Release, Drug Delivery and Translational Research, Pharmaceutical Research, Investigational New Drugs and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.